Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer

Oettle, Helmut; Neuhaus, P.; Hochhaus, Andreas; T. Hartmann, Jörg; Gellert, Klaus; Ridwelski, Karsten; Niedergethmann, Marco; Zülke, C.; Fahlke, Jörg; Arning, M.; Sinn, Marianne; Hinke, Axel; Riess, Hanno

doi:10.1001/jama.2013.279201

Public

Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer

Published in JAMA • Oct 8, 2013

Authors:

Helmut Oettle

P. Neuhaus

Andreas Hochhaus

Abstract

IMPORTANCE: The prognosis for patients with pancreatic cancer is poor, even after resection with curative intent. Gemcitabine-based chemotherapy is standard treatment for advanced pancreatic cancer, but its effect on survival in the adjuvant setting has not been demonstrated. OBJECTIVE: To analyze w...

Subject

Medicine

Gemcitabine

Pancreatic cancer

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!